- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02538900
Low InTensity Exercise Intervention in PAD (LITE)
연구 개요
상세 설명
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Illinois
-
Chicago, Illinois, 미국, 60611
- Northwestern University
-
-
Louisiana
-
New Orleans, Louisiana, 미국, 70121
- Ochsner Baptist, Tulane University
-
-
Minnesota
-
Minneapolis, Minnesota, 미국, 55455
- University of Minnesota
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, 미국, 15213
- University of Pittsburgh Medical Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
All participants will have PAD. PAD will be defined as follows. First, an ABI < or = 0.90 at the baseline study visit is a well-accepted standard for the diagnosis of PAD and will be an inclusion criterion. Second, people with an ABI of >0.90 and < or = 1.00 who experience a 20% ankle systolic pressure drop after the heel-rise test will also be included. Third, potential participants with an ABI > 0.90 who have vascular lab evidence of PAD or angiographic evidence of PAD who have ischemic symptoms during the six-minute walk and/or treadmill exercise stress test will be eligible. In addition to meeting a criterion for PAD, all participants must be symptomatic, defined by one of the following criteria:; a) ischemic leg symptoms (primarily assessed with the San Diego Claudication Questionnaire); b) report ischemic leg symptoms at the end of the six-minute walk; c) report ischemic leg symptoms at the end of the baseline treadmill stress test; d) walking impairment questionnaire results, e) interview with the potential participant about the presence and nature of leg symptoms during walking activity.
Exclusion Criteria:
- Above or below knee amputation, critical limb ischemia, wheelchair confinement, or foot ulcer.
- Individuals whose walking is limited by a condition other than PAD.
- > Class II NYHA heart failure or angina. Increase in angina, angina at rest, or abnormal baseline treadmill stress test.
- Major surgery including lower extremity revascularization or orthopedic surgery during the prior three months or anticipated in the next twelve months.
- Major medical illness including renal disease requiring dialysis, lung disease requiring oxygen other than at night, or cancer (other than non-melanoma skin cancer) requiring treatment in the prior three years. Potential participants may still qualify if they have had treatment for early stage cancer in the previous three years and the prognosis is excellent.
- Mini-mental status examination score <23, dementia, or psychiatric illness including severe depression or anxiety. Investigator discretion may be used to allow some people with an MMSE below 23 to participate if the investigator determines there is another reason for their lower score, including lack of sufficient familiarity with the English language or lack of sufficient education to achieve a score of 23 or higher.
- Currently walking regularly for exercise at a level comparable to the amount of exercise prescribed in the intervention.
- Current or recent (within 3 months) participation in another clinical trial or cardiac rehabilitation. For a clinical trial of a stem cell or gene therapy intervention, potential participants will be potentially eligible immediately after the final study visit for the clinical trial, so long as long as at least six months has passed since the participant received their final treatment in the stem cell or gene therapy intervention. For a clinical trial involving open-label therapy in which the treatment is not related to functional performance and will not change during the LITE Trial, participants may still qualify for the LITE Trial based on investigator discretion.
- Individuals with PAD who have a history of lower extremity revascularization and have a normal ABI.
- Individuals who are not able to walk for exercise at a sufficiently slow pace to avoid ischemic leg symptoms.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Group 1
Low-intensity, self-paced walking exercise.
Home based exercise.
|
Participants in one of the exercise intervention groups will attend once weekly sessions at the medical center for the first four weeks of the study (Weeks 1-4, Phase I).
During weeks 5-52 (Phase II), they will receive weekly telephone calls from a study coach.
|
실험적: Group 2
Standard high intensity, ischemic pain-inducing walking exercise.
Home based exercise.
|
Participants in one of the exercise intervention groups will attend once weekly sessions at the medical center for the first four weeks of the study (Weeks 1-4, Phase I).
During weeks 5-52 (Phase II), they will receive weekly telephone calls from a study coach.
|
활성 비교기: Group 3
Non-exercising attention control group.
Contact with staff at same frequency as exercise groups, but staff deliver information on health not related to exercise.
|
Our attention control group controls for the possibility that regular contact with the study team may improve outcomes in participants randomized to the intervention.
Participants randomized to the control group will attend weekly one-hour educational sessions at Northwestern University for the first four weeks of the intervention (Phase I).
These sessions are on topics of interest to the typical PAD patient and are led by physicians and other health care workers.
Topics include Medicare Part D, nutritional supplements, and cancer screening.
During Phase II (weeks 5-52), the attention control group will receive weekly telephone calls, lasting 5-15 minutes, with information on a health-related topic.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Six-minute Walk Distance
기간: change from baseline to week 52
|
In the six-minute walk, participants walk back and forth along a 100-ft hallway for six minutes after standardized instructions to complete as many laps as possible.
Distance covered in six minutes is recorded.
|
change from baseline to week 52
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Six-minute Walk Distance
기간: change from baseline to week 26
|
In the six-minute walk, participants walk back and forth along a 100-ft hallway for six minutes after standardized instructions to complete as many laps as possible.
Distance covered in six minutes is recorded.
|
change from baseline to week 26
|
Maximal Treadmill Walking Time
기간: change from baseline to week 52
|
In the treadmill walking test, participants walk on either a gardner or modified gardner protocol until they stop the test.
Time walked is recorded
|
change from baseline to week 52
|
Physical Activity Levels
기간: Change from baseline to week 52
|
ActiGraph measured physical activity
|
Change from baseline to week 52
|
Walking Impairment Questionnaire (WIQ) Distance and Speed Score.
기간: change from baseline to week 52
|
The WIQ is a well validated questionnaire that measures patient-reported walking limitations in distance and speed.
|
change from baseline to week 52
|
Health-related Quality of Life Measure
기간: change from baseline to week 52
|
The SF-36 physical functioning score will be used to measure quality of life.
|
change from baseline to week 52
|
Adherence to Intervention
기간: from baseline to week 52
|
Adherence is defined as the proportion achieving at least 80% of the prescribed exercise frequency and duration during the final month of the intervention.
|
from baseline to week 52
|
Change in Muscle Biopsy Measures of Mitochondrial Oxidative Metabolism and Oxidative Stress.
기간: change from baseline to week 52
|
Muscle tissue will be collected at baseline and follow up to measures Change in muscle biopsy measures of mitochondrial oxidative metabolism and oxidative stress.
|
change from baseline to week 52
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Qualitative Assessment
기간: At 52 week follow up
|
We will use qualitative methods to explore participants' perceptions of the exercise interventions in the high and low-intensity exercise groups, respectively.
|
At 52 week follow up
|
Physical Activity Levels Over Seven Days
기간: 26 week follow-up.
|
ActiGraph
|
26 week follow-up.
|
WIQ Distance and Speed Score
기간: 26 week follow-up
|
The WIQ is a well validated questionnaire that measures patient-reported walking limitations in distance and speed.
|
26 week follow-up
|
Health Related Quality of Life
기간: 26 weeks
|
SF-36 physical functioning score.
|
26 weeks
|
Adherence to Assigned Intervention
기간: 26 weeks.
|
Adherence is defined as the proportion achieving at least 80% of the prescribed exercise frequency and duration during the final month of the intervention.
|
26 weeks.
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Mary McDermott, MD, Northwestern University
간행물 및 유용한 링크
일반 간행물
- Hammond MM, Spring B, Rejeski WJ, Sufit R, Criqui MH, Tian L, Zhao L, Xu S, Kibbe MR, Leeuwenburgh C, Manini T, Forman DE, Treat-Jacobson D, Polonsky TS, Bazzano L, Ferrucci L, Guralnik J, Lloyd-Jones DM, McDermott MM. Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial. J Am Heart Assoc. 2022 Aug 2;11(15):e025063. doi: 10.1161/JAHA.121.025063. Epub 2022 Jul 27.
- Slysz JT, Rejeski WJ, Treat-Jacobson D, Bazzano LA, Forman DE, Manini TM, Criqui MH, Tian L, Zhao L, Zhang D, Guralnik JM, Ferrucci L, Kibbe MR, Polonsky TS, Spring B, Sufit R, Leeuwenburgh C, McDermott MM. Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial. Vasc Med. 2021 Oct;26(5):497-506. doi: 10.1177/1358863X21989430. Epub 2021 Apr 8.
- McDermott MM, Spring B, Tian L, Treat-Jacobson D, Ferrucci L, Lloyd-Jones D, Zhao L, Polonsky T, Kibbe MR, Bazzano L, Guralnik JM, Forman DE, Rego A, Zhang D, Domanchuk K, Leeuwenburgh C, Sufit R, Smith B, Manini T, Criqui MH, Rejeski WJ. Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial. JAMA. 2021 Apr 6;325(13):1266-1276. doi: 10.1001/jama.2021.2536.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
말초 동맥 질환에 대한 임상 시험
-
C. R. Bard완전한
-
Mayo Clinic초대로 등록
-
Micell TechnologiesCardialysis BV; ClinLogix. LLC알려지지 않은
-
University Medical Center Groningen모병
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); US Department...완전한신장 질환 | 만성 신장 질환 | 급성 신부전 | 관상동맥(Artery); 질병
Exercise에 대한 임상 시험
-
University of TorontoUniversity Health Network, Toronto; University of Western Ontario, Canada; Institute for... 그리고 다른 협력자들완전한
-
The Hong Kong Polytechnic University완전한
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)완전한